Torrent launches world's first cardiac pill

Pharma major Torrent Pharmaceuticals Ltd has announced the launch of cardiovascular pill (CVpill).

According to the company, with CVpill, Torrent Pharma has become the first company to actually launch a polypill. A company release claims that CVpill is the world's first polypill in cardiac care.

Ruchir Modi, Head, Strategic Marketing, says, with CVpill, the company has created a completely new segment in cardiology care and aims to clock over Rs 10 crore in sales in the first year of its launch.

A patients with multiple cardiovascular risk factors have to take 4-5 medications everyday. The treatment is expensive and there is always the risk of the patient forgetting to take a medicine. The CVpill lets patients experience the simplicity of an 'all-in-one' medication at a cost-effective price.

CVpill is available in a kit containing a capsule and a tablet. The capsule contains a statin (Atorvastatin 10 mg), an ACE inhibitor (Ramipril 5 mg) and an anti-platelet agent (Enteric-coated Aspirin 75 mg).

The tablet contains a beta blocker (Metoprolol Succinate extended release 50 mg). The CVpill is an innovative combination of these four most recommended molecules used in the treatment for multiple cardiovascular (CV) risk factors.

All the four constituents of this kit are standalone molecules with a huge prescription volume and a combined market worth Rs 500 crore.